Pharma Mar SA(PHMMF)
$75.44-1.55 (-2.01%)
PHMMF
Pharma Mar SA earnings date
$75.44
At close:-1.55 (-2.01%)
Pharma Mar SA (PHMMF) Q2 2026 Earnings Report
60 Followers
PHMMF Q2 2026 EPS Results
- Actual EPS
- -$0.07
- Consensus EPS
- $0.20
- Beat/Miss
- Missed by -$0.26
- One Year Ago EPS
- $1.47
PHMMF Q2 2026 Revenue Results
- Actual Revenue
- $54.88M
- Expected Revenue
- $49.75M
- Beat/Miss
- Beat by +$5.12M
- YoY Revenue Growth
- -12.04%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/29/2026
- Time
- TBA
- Conference Call
- Wednesday, July 29, 2026
PHMMF Upcoming Earnings
Pharma Mar SA's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
PHMMF Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
PHMMF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | 1.09- | 3.69 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.140.52 | -0.14 | 461.54% (+0.66) | |
| Jul 29, 2026 | 2026 (Q2) | 0.20-0.07 | 1.47 | -104.53% (-1.53) | |
| Apr 23, 2026 | 2026 (Q1) | 0.140.10 | -0.12 | 181.82% (+0.22) | |
| Feb 27, 2026 | 2025 (Q4) | 3.403.69 | 1.16 | 219.14% (+2.53) | |
| Oct 30, 2025 | 2025 (Q3) | -0.17-0.14 | 0.22 | -165.00% (-0.37) | |
| Jul 30, 2025 | 2025 (Q2) | ―1.47 | 0.07 | 1938.46% (+1.39) | |
| Apr 24, 2025 | 2025 (Q1) | 0.35-0.12 | 0.13 | -191.67% (-0.25) | |
| Feb 28, 2025 | 2024 (Q4) | 1.071.16 | -0.42 | 375.00% (+1.58) | |
| Oct 29, 2024 | 2024 (Q3) | 0.230.22 | 0.09 | 150.00% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
